ArticleJournal of thoracic disease2024
Prognostic significance using histologic subtype in stage I lung adenocarcinoma.
Article in Journal of thoracic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lymphatic Invasion Acts as a 'Hidden Risk Factor': Four-Fold Increased Mortality Risk in Early-Stage (TNM Stage I, N0) Non-Small Cell Lung Cancer.Journal of clinical medicine · 2026Article
- Survival risk prediction for patients with lung adenocarcinoma containing micropapillary components based on weakly supervised pathomics.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The pathologic feature of lung adenocarcinoma is extremely complex because the prognosis of same-stage lung adenocarcinoma significantly differs because of pathological diversity. This study aimed to evaluate the clinical association between histologic subtype and recurrence. Further, the prognostic significance of histologic subtype in stage I lung adenocarcinoma was examined. Methods: The medical records of 752 patients with pathological stage I lung adenocarcinoma were reviewed. The size of each histologic subtype was assessed. Receiver operating characteristic curve analysis was performed to identify the prognostic significance of histologic subtype. Univariate and multivariate analyses were conducted to validate the prognostic role of recurrence indicator. Results: The median age of the participants was 64 years, and female patients were predominant. The acinar-predominant subtype (44.7%) was the most common. According to each subtype size for predicting recurrence, >1 cm size of acinar subtype showed significant difference and the only presence of micropapillary and solid subtype themselves showed significant difference. As the area under the receiver operating characteristic curve for recurrence, an acinar subtype size of >1 cm, or the presence of the micropapillary or solid subtypes was 0.710 (P<0.001). This variable was significant for recurrence in the multivariate analysis (P<0.001). Conclusions: The presence of micropapillary, solid subtype or an acinar size of >1 cm are an independent prognostic factor of stage I lung adenocarcinoma. A more sizable acinar subtype affects the prognosis of stage I lung adenocarcinoma. This factor can provide additional information for predicting prognosis and can be a valuable supplement for the current classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.